Position in MRK
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$3,805,013
+$297,598 QoQ
Shares Held
29,611
+1.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#1,180
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rehmann Capital Advisory Group holds $37,318,224 across 12 Drug Manufacturers - General names. MRK ranks #3 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
38,703 | $9,829,400 | |
| 2 | LLY |
ELI LILLY & Co
|
5,246 | $6,292,210 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
29,611 | $3,805,013 | |
| 4 | PFE |
Pfizer Inc
|
152,066 | $3,661,749 | |
| 5 | ABBV |
AbbVie Inc.
|
12,987 | $3,268,048 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
42,344 | $2,439,861 | |
| 7 | AMGN |
Amgen Inc
|
6,083 | $2,202,775 | |
| 8 | AZN |
Astrazeneca PLC
|
10,283 | $1,949,862 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,805,013 | 29,611 | Shares | Sole | 2026-08-20 | |
| 2026-03-31 | $3,507,415 | 29,158 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,978,963 | 28,301 | Shares | Sole | 2026-03-04 | |
| 2025-09-30 | $2,548,114 | 30,360 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,628,428 | 33,204 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $2,943,679 | 32,795 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $3,278,761 | 32,959 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,731,240 | 32,857 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $3,732,570 | 30,150 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,509,738 | 26,599 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $2,921,081 | 26,794 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,764,516 | 26,853 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,139,761 | 27,210 | Shares | Sole | 2023-08-23 | |
| 2023-03-31 | $2,907,851 | 27,332 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,081,636 | 27,775 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,342,377 | 27,199 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,570,994 | 28,200 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,209,114 | 26,924 | Shares | Sole | 2022-06-03 | |
| 2021-12-31 | $1,950,258 | 25,447 | Shares | Sole | 2022-03-02 | |
| 2021-09-30 | $1,931,303 | 25,713 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $2,015,642 | 25,918 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,100,703 | 27,250 | Shares | Sole | 2021-05-26 | |
| 2020-12-31 | $2,111,747 | 25,816 | Shares | Sole | 2021-02-19 | |
| 2020-09-30 | $2,146,912 | 25,882 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $1,949,954 | 25,216 | Shares | Sole | 2020-11-20 | |
| 2020-03-31 | $1,977,972 | 25,708 | Shares | Sole | 2020-11-20 | |
| No filing history on record for this holder in this stock. | ||||||